首页> 外文会议>Society for Biomaterials annual meeting and exposition >Polyanhydride Nanovaccines Elicit Protective Virus Neutralizing Titers and Cell-mediated Immunity Against Influenza
【24h】

Polyanhydride Nanovaccines Elicit Protective Virus Neutralizing Titers and Cell-mediated Immunity Against Influenza

机译:聚酸酐Nanovaccines引起保护性病毒中和滴度和针对流感的细胞介导的免疫力

获取原文

摘要

The studies herein demonstrate the strong immunogenic properties of the H5_3 antigen. All formulations displayed neutralizing antibody titers similar to a MPLA-adjuvanted control, while the poly I:C + nanovaccine formulation enhanced CD4~+ T cell proliferation. Upon challenge with a live virus, H5_3-vaccinated mice were protected laying a foundation for the polyanhydride nanovaccine platform in developing influenza vaccines.
机译:本文的研究证明了H5_3抗原的强免疫原性。所有制剂均显示出与MPLA佐剂相似的中和抗体效价,而聚I:C +纳米疫苗制剂可增强CD4〜+ T细胞增殖。受到活病毒攻击后,H5_3疫苗接种的小鼠受到保护,为开发流感疫苗的聚酸酐纳米疫苗平台奠定了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号